Schott has appointed Christophe Muguet as vice president of its global syringe business, based in St Gallen, Switzerland.
Muguet now leads the global syringe business activities of Schott Pharmaceutical Packaging and is responsible for business development, product management, research and development and operations.
He has joined Schott from Becton Dickinson, where he was vice president of industrial operations, which included responsibility for global operations of the company’s pharmaceutical systems business unit with six production sites in France, Hungary, Japan, Mexico, UK and the US.
Prior to this, Muguet held several positions at Becton Dickinson in the fields of supply chain, IT and planning. Altogether, he spent 17 years at the US-based medical technology company.
Before joining Becton Dickinson, Muguet worked in the fields of procurement, production and supply chain at GlaxoSmithKline and Serono.
Schott appoints vp of global syringe business
Christophe Muguet joins the firm from Becton Dickinson
You may also like
Design & Build
SCHOTT Pharma invests in sterile cartridge production in Hungary
SCHOTT Pharma breaks ground for a new production facility for ready-to-use cartridges in Hungary. Its investment of over EUR 100 million is part of the company’s expansion strategy to meet the growing market demand for high-value solutions
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
The critical role of uniform-quality containers for drug manufacturing efficiency
By investing in highly uniform containers that meet precise tolerances, manufacturers can optimise processing efficiency by increasing automation, minimising downtime and reducing waste — all of which lead to indirect cost savings that far outweigh the initial cost savings of using lower-priced goods
Packaging
SCHOTT Pharma introduces blister-free syringe concept
As part of the Alliance to Zero goal to facilitate the pharmaceutical industry's transition to net-zero emissions, SCHOTT Pharma has teamed up with Schreiner MediPharm and Körber Pharma to develop a groundbreaking blister-free syringe concept